You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》艾迪康(09860.HK)暗盤高開1.6%報12.52元 現倒跌一成
根據輝立交易平台顯示,明天掛牌的艾迪康控股(09860.HK)暗盤高開1.6%報12.52元欠承接,掉頭低見11.04元,現報11.1元,較上市價12.32元,低9.9%,成交5.2萬股。 艾迪康是中國三大獨立醫學實驗室(或ICL)服務提供商之一。是次在港上市以每股12.32元合共發售3,319.25萬股(包括1,590.4萬舊股),並已引入包括邁瑞醫療(300760.SZ)旗下邁瑞全球、新產業(300832.SZ)旗下香港新產業、復星醫藥(02196.HK)旗下復星診斷、Timestar Elite及Corelink五名基石投資者,合共認購2,364.7萬股;10%公開發售獲0.06倍超購,人人有份,料淨籌8,390萬元,主要用於加強普檢和特檢能力;通過新建實驗室、新增合夥投資和開發新渠道拓展網絡;與行業參與者形成戰略合作的 業務開發活動以及戰略性及附加收購;升級與擴大現有實驗室;以及投資營運基礎設施等。由摩根士丹利亞洲及富瑞金融集團香港擔任聯席保薦人。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account